Androgen suppression therapy (ADT), also known as hormone therapy, is a medical treatment that lowers the levels of male hormones, called androgens (primarily testosterone). It's primarily used for treating prostate cancer and sometimes other conditions that are affected by androgens.
Market Analysis and Insights: Global Androgen Suppression Therapy Market
The global Androgen Suppression Therapy market is projected to grow from US$ 11300 million in 2024 to US$ 15320 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
The Androgen Suppression Therapy (ADT) market is expected to see steady growth in the coming years, driven by several key factors:
Market Drivers:
Rising incidence of prostate cancer: Prostate cancer is the most common cancer among men worldwide, and Androgen Suppression Therapy remains a cornerstone treatment option, fueling market demand.
Aging population: With an increasing aging population, the prevalence of prostate cancer and other conditions treated with Androgen Suppression Therapy is expected to rise, further propelling market growth.
Evolving treatment protocols: Advancements in medical research are leading to new and personalized approaches to Androgen Suppression Therapy, including shorter treatment durations and combination therapies, expanding market options.
Increasing awareness and access to treatment: Growing awareness about prostate cancer and its treatment options, coupled with improved healthcare access in some regions, is driving higher uptake of Androgen Suppression Therapy.
Development of novel formulations and delivery systems: Advancements in drug delivery, like long-acting injectable medications and oral medications with fewer side effects, are improving patient compliance and potentially expanding the market reach.
Challenges and Future Outlook:
Cost-effectiveness concerns: Androgen Suppression Therapy can be expensive, and rising healthcare costs could limit accessibility for patients in some regions.
Side effects and long-term health impacts: The potential side effects of Androgen Suppression Therapy, including bone loss and cardiovascular risks, require ongoing research and development of safer and more effective treatment options.
Patient compliance: Addressing concerns about side effects and ensuring adherence to treatment protocols remain crucial for achieving optimal treatment outcomes.
Despite these challenges, the Androgen Suppression Therapy market holds promising potential for sustained growth. Continued research into novel therapies, improved access to treatment, and developing personalized treatment plans will be key factors in shaping the future of this market.
Report Covers:
This report presents an overview of global market for Androgen Suppression Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Androgen Suppression Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgen Suppression Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Androgen Suppression Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgen Suppression Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgen Suppression Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
Segment by Type
Tablet
Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Androgen Suppression Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Suppression Therapy companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Suppression Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Suppression Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Androgen Suppression Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgen Suppression Therapy Market Perspective (2019-2030)
2.2 Global Androgen Suppression Therapy Growth Trends by Region
2.2.1 Androgen Suppression Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgen Suppression Therapy Historic Market Size by Region (2019-2024)
2.2.3 Androgen Suppression Therapy Forecasted Market Size by Region (2025-2030)
2.3 Androgen Suppression Therapy Market Dynamics
2.3.1 Androgen Suppression Therapy Industry Trends
2.3.2 Androgen Suppression Therapy Market Drivers
2.3.3 Androgen Suppression Therapy Market Challenges
2.3.4 Androgen Suppression Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Androgen Suppression Therapy by Players
3.1.1 Global Androgen Suppression Therapy Revenue by Players (2019-2024)
3.1.2 Global Androgen Suppression Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Suppression Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Androgen Suppression Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Androgen Suppression Therapy Market Concentration Ratio
3.4.1 Global Androgen Suppression Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Suppression Therapy Revenue in 2023
3.5 Global Key Players of Androgen Suppression Therapy Head office and Area Served
3.6 Global Key Players of Androgen Suppression Therapy, Product and Application
3.7 Global Key Players of Androgen Suppression Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Suppression Therapy Breakdown Data by Type
4.1 Global Androgen Suppression Therapy Historic Market Size by Type (2019-2024)
4.2 Global Androgen Suppression Therapy Forecasted Market Size by Type (2025-2030)
5 Androgen Suppression Therapy Breakdown Data by Application
5.1 Global Androgen Suppression Therapy Historic Market Size by Application (2019-2024)
5.2 Global Androgen Suppression Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgen Suppression Therapy Market Size (2019-2030)
6.2 North America Androgen Suppression Therapy Market Size by Type
6.2.1 North America Androgen Suppression Therapy Market Size by Type (2019-2024)
6.2.2 North America Androgen Suppression Therapy Market Size by Type (2025-2030)
6.2.3 North America Androgen Suppression Therapy Market Share by Type (2019-2030)
6.3 North America Androgen Suppression Therapy Market Size by Application
6.3.1 North America Androgen Suppression Therapy Market Size by Application (2019-2024)
6.3.2 North America Androgen Suppression Therapy Market Size by Application (2025-2030)
6.3.3 North America Androgen Suppression Therapy Market Share by Application (2019-2030)
6.4 North America Androgen Suppression Therapy Market Size by Country
6.4.1 North America Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Androgen Suppression Therapy Market Size by Country (2019-2024)
6.4.3 North America Androgen Suppression Therapy Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Androgen Suppression Therapy Market Size (2019-2030)
7.2 Europe Androgen Suppression Therapy Market Size by Type
7.2.1 Europe Androgen Suppression Therapy Market Size by Type (2019-2024)
7.2.2 Europe Androgen Suppression Therapy Market Size by Type (2025-2030)
7.2.3 Europe Androgen Suppression Therapy Market Share by Type (2019-2030)
7.3 Europe Androgen Suppression Therapy Market Size by Application
7.3.1 Europe Androgen Suppression Therapy Market Size by Application (2019-2024)
7.3.2 Europe Androgen Suppression Therapy Market Size by Application (2025-2030)
7.3.3 Europe Androgen Suppression Therapy Market Share by Application (2019-2030)
7.4 Europe Androgen Suppression Therapy Market Size by Country
7.4.1 Europe Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Androgen Suppression Therapy Market Size by Country (2019-2024)
7.4.3 Europe Androgen Suppression Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Androgen Suppression Therapy Market Size (2019-2030)
8.2 China Androgen Suppression Therapy Market Size by Type
8.2.1 China Androgen Suppression Therapy Market Size by Type (2019-2024)
8.2.2 China Androgen Suppression Therapy Market Size by Type (2025-2030)
8.2.3 China Androgen Suppression Therapy Market Share by Type (2019-2030)
8.3 China Androgen Suppression Therapy Market Size by Application
8.3.1 China Androgen Suppression Therapy Market Size by Application (2019-2024)
8.3.2 China Androgen Suppression Therapy Market Size by Application (2025-2030)
8.3.3 China Androgen Suppression Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Androgen Suppression Therapy Market Size (2019-2030)
9.2 Asia Androgen Suppression Therapy Market Size by Type
9.2.1 Asia Androgen Suppression Therapy Market Size by Type (2019-2024)
9.2.2 Asia Androgen Suppression Therapy Market Size by Type (2025-2030)
9.2.3 Asia Androgen Suppression Therapy Market Share by Type (2019-2030)
9.3 Asia Androgen Suppression Therapy Market Size by Application
9.3.1 Asia Androgen Suppression Therapy Market Size by Application (2019-2024)
9.3.2 Asia Androgen Suppression Therapy Market Size by Application (2025-2030)
9.3.3 Asia Androgen Suppression Therapy Market Share by Application (2019-2030)
9.4 Asia Androgen Suppression Therapy Market Size by Region
9.4.1 Asia Androgen Suppression Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Androgen Suppression Therapy Market Size by Region (2019-2024)
9.4.3 Asia Androgen Suppression Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Suppression Therapy Introduction
11.1.4 Pfizer Revenue in Androgen Suppression Therapy Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Astellas
11.2.1 Astellas Company Details
11.2.2 Astellas Business Overview
11.2.3 Astellas Androgen Suppression Therapy Introduction
11.2.4 Astellas Revenue in Androgen Suppression Therapy Business (2019-2024)
11.2.5 Astellas Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Suppression Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Suppression Therapy Business (2019-2024)
11.3.5 Johnson & Johnson Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Androgen Suppression Therapy Introduction
11.4.4 AstraZeneca Revenue in Androgen Suppression Therapy Business (2019-2024)
11.4.5 AstraZeneca Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Androgen Suppression Therapy Introduction
11.5.4 Bayer Revenue in Androgen Suppression Therapy Business (2019-2024)
11.5.5 Bayer Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Androgen Suppression Therapy Introduction
11.6.4 Merck Revenue in Androgen Suppression Therapy Business (2019-2024)
11.6.5 Merck Recent Developments
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Androgen Suppression Therapy Introduction
11.7.4 Tolmar Revenue in Androgen Suppression Therapy Business (2019-2024)
11.7.5 Tolmar Recent Developments
11.8 Zoladex
11.8.1 Zoladex Company Details
11.8.2 Zoladex Business Overview
11.8.3 Zoladex Androgen Suppression Therapy Introduction
11.8.4 Zoladex Revenue in Androgen Suppression Therapy Business (2019-2024)
11.8.5 Zoladex Recent Developments
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Details
11.9.2 Ferring Pharmaceuticals Business Overview
11.9.3 Ferring Pharmaceuticals Androgen Suppression Therapy Introduction
11.9.4 Ferring Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024)
11.9.5 Ferring Pharmaceuticals Recent Developments
11.10 Jiangsu Hengrui Pharmaceuticals
11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024)
11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
11.11 CTTQ
11.11.1 CTTQ Company Details
11.11.2 CTTQ Business Overview
11.11.3 CTTQ Androgen Suppression Therapy Introduction
11.11.4 CTTQ Revenue in Androgen Suppression Therapy Business (2019-2024)
11.11.5 CTTQ Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
听
听
*If Applicable.
